首页> 外文期刊>Journal of dietary supplements >Cannabis sativa L. and Its Extracts: Regulation of Cannabidiol in the European Union and United Kingdom
【24h】

Cannabis sativa L. and Its Extracts: Regulation of Cannabidiol in the European Union and United Kingdom

机译:大麻苜蓿及其提取物:在欧洲联盟和英国的麻痹调节

获取原文
获取原文并翻译 | 示例
       

摘要

The lawful sale of Cannabis sativa L. and its extracts including Cannabidiol is not harmonized under European Union law. Such products have in the most part been classified as novel foods and thus illegal for sale in Europe without prior authorization. The regulation of such substances not only spans EU and Member State food laws but also international conventions on illicit drug and psychoactive substances. An understanding of the laws governing the sale of these compounds can help business and academia better understand the challenges consumers may face in selecting products lawfully placed on the market, whilst identifying the unique challenges imposed from the marketing of Cannabis-based foods.
机译:根据欧盟法律,大麻及其提取物(包括大麻二酚)的合法销售并不统一。这类产品在很大程度上被列为新型食品,因此未经事先授权在欧洲销售是非法的。对此类物质的监管不仅涉及欧盟和成员国的食品法,还涉及关于非法药物和精神活性物质的国际公约。了解有关这些化合物销售的法律,可以帮助企业和学术界更好地了解消费者在选择合法投放市场的产品时可能面临的挑战,同时确定大麻食品营销带来的独特挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号